The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

GSK has announced a partnership with the UK Dementia Research Institute and Health Data Research UK to explore a potential ...

The UK government is providing £2 million ($2.6 million) in funding to allow digital assessment to be added to a ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

To test it prospectively, GSK will work with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) ...

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

Prominent outside scientists who help the NIH evaluate its internal research programs are being abruptly removed ...

GSK, led by boss Emma Walmsley (pictured), is using the data of 1.4m adults aged 65 and 66 to examine the impact of its ...

UK pharma major GSK (LSE: GSK) today announced a major new research collaboration with the UK Dementia Research Institute (UK ...

The recombinant zoster vaccine is effective in preventing herpes zoster in adults aged 50 years or older with rheumatoid ...